Search Within

Megan Alexandra Tenet

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (4)
  2. Department of Medicine (4)
  3. Department of Pathology and Laboratory Medicine (4)
  4. Epidemiology and Biostatistics (4)
  5. GSK Faculty (4)
  6. Human Oncology and Pathogenesis Program (4)

More Groups

People
  1. Hira Rizvi (4)
  2. Marc Ladanyi (4)
  3. Matthew Hellmann (4)
  4. Charles Rudin (3)
  5. Helena Yu (3)
  6. Maria Arcila (3)

More People

Years
  1. 2019 (2)
  2. 2018 (2)
Publications
  1. Journal of Thoracic Oncology (2)
  2. Clinical Cancer Research (1)
  3. Journal of Clinical Oncology (1)
Publishers
  1. Elsevier Inc. (2)
  2. American Association for Cancer Research (1)
  3. American Society of Clinical Oncology (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes
    Journal Article

    Offin, M.; Chan, J. M.; Tenet, M.; Rizvi, H. A.; Shen, R.; Riely, G. J.; Rekhtman, N.; Daneshbod, Y.; Quintanal-Villalonga, A.; Penson, A.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Tumor mutation burden and efficacy of EGFR-tyrosine kinase inhibitors in patients with EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez-Vega, F.; Li, B. T.; Drilon, A.; Kris, M. G.; Rudin, C. M.; Schultz, N.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC
    Meeting Abstract

    Rizvi, H.; Plodkowski, A. J.; Tenet, M.; Halpenny, D.; Long, N.; Sauter, J. L.; Sanchez-Vega, F.; Chatila, W. K.; Schultz, N.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of EGFR mutant lung cancers with concurrent TP53 and RB1 mutations
    Meeting Abstract

    Offin, M.; Tenet, M.; Shen, R.; Rekhtman, N.; Rizvi, H.; Hellmann, M.; Arcila, M.; Ladanyi, M.; Rudin, C.; Kris, M.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save